跳至主要内容
临床试验/JPRN-UMIN000050122
JPRN-UMIN000050122尚未招募Unknown

A single-center, prospective, randomized, exploratory study to investigate the influence of ARNI (angiotensin receptor neprilysin inhibitor) in patients with hemodialysis and heart failure: SPREAD trial - Exploratory study to investigate the influence of ARNI in patients with hemodialysis and heart failure

Masuko Memorial Hospital0 个研究点目标入组 374 人开始时间: 2023年2月1日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
374

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients who had hypotension before or during the last 3-cycle hemodialysis 2)Hyperkalemia 3)Patients with severe liver disease 4)Patients with a history of hospitalization due to ischemic heart disease or stroke within 3 months. 5)Patients under an unstable heart failure condition 6)Patients with a life expectancy less than 1 year 7)Patients with acute phase disease requiring hospitalization 8)Patients with severe valvular disease 9)Patients with severe respiratory disease 10)Pregnant patients 11)Patients who are suspected of drug allergy to sacubitril-valsartan 12)Patients unable to communicate 13)Patients who are judged inappropriate for this study by investigators

研究者

发起方
Masuko Memorial Hospital

相似试验